|CCL 17.06.08 Solutions Architect, Drug Discovery, Schrödinger, NYC|
From: jobs at ccl.net (do not send your application there!!!)
To: jobs at ccl.net
Date: Thu Jun 8 10:52:56 2017
Subject: 17.06.08 Solutions Architect, Drug Discovery, Schrödinger, NYC
Schrödinger's mission is to revolutionize drug discovery through the use of breakthrough computational methods. We are currently looking for outstanding individuals to join our drug discovery group and contribute to our rapidly expanding portfolio of drug discovery collaborations.
Our drug discovery group of over 40 scientists includes designers, modelers, computational chemists, medicinal chemists, crystallographers, biochemists, and biologists. The group is supported by more than 100 software developers and engineers. Three of the programs weve worked on in the past 5 years have progressed into the clinic and an additional one is expected to enter clinical trials next year.
If you are interested in constructing and maintaining enterprise chemical information systems in support of our drug discovery group, we are eager to hear from you.
Skills and Talents
We offer highly competitive compensation packages. Benefits include medical, dental, vision, 401(k), flexible spending account, 3+ weeks vacation, tuition reimbursement and a flexible work environment.
Please apply directly via our website at: https://www.schrodinger.com/careers/software-engineers/solutions-architect-drug-discovery
Schrödinger, Inc. is an equal opportunity employer.NOTE THAT E-MAIL ADDRESSES HAVE BEEN MODIFIED!!!
All @ signs were changed to ** to fight spam. Before you send e-mail, you need to change ** to @
For example: change joe**big123comp.com to firstname.lastname@example.org
Please let your prospective employer know that you learned about the job from the Computational Chemistry List Job Listing at http://www.ccl.net/jobs. If you are not interested in this particular position yourself, pass it to someone who might be -- some day they may return the favor.
|Modified: Thu Jun 8 14:52:56 2017 GMT|
|Page accessed 982 times since Thu Jun 8 15:20:50 2017 GMT|